When more is more: the role of additional upfront therapy in pulmonary arterial hypertension

Early combination therapy targeting several relevant pathogenic pathways, including the prostacyclin pathway, is likely to be of benefit to most patients with PAH https://bit.ly/3GisHnA

Detalles Bibliográficos
Autores principales: Niedermeyer, Shannon, Hassoun, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841312/
https://www.ncbi.nlm.nih.gov/pubmed/36687364
http://dx.doi.org/10.1183/23120541.00592-2022
_version_ 1784869810715230208
author Niedermeyer, Shannon
Hassoun, Paul
author_facet Niedermeyer, Shannon
Hassoun, Paul
author_sort Niedermeyer, Shannon
collection PubMed
description Early combination therapy targeting several relevant pathogenic pathways, including the prostacyclin pathway, is likely to be of benefit to most patients with PAH https://bit.ly/3GisHnA
format Online
Article
Text
id pubmed-9841312
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-98413122023-01-19 When more is more: the role of additional upfront therapy in pulmonary arterial hypertension Niedermeyer, Shannon Hassoun, Paul ERJ Open Res Editorials Early combination therapy targeting several relevant pathogenic pathways, including the prostacyclin pathway, is likely to be of benefit to most patients with PAH https://bit.ly/3GisHnA European Respiratory Society 2023-01-16 /pmc/articles/PMC9841312/ /pubmed/36687364 http://dx.doi.org/10.1183/23120541.00592-2022 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Editorials
Niedermeyer, Shannon
Hassoun, Paul
When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
title When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
title_full When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
title_fullStr When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
title_full_unstemmed When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
title_short When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
title_sort when more is more: the role of additional upfront therapy in pulmonary arterial hypertension
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841312/
https://www.ncbi.nlm.nih.gov/pubmed/36687364
http://dx.doi.org/10.1183/23120541.00592-2022
work_keys_str_mv AT niedermeyershannon whenmoreismoretheroleofadditionalupfronttherapyinpulmonaryarterialhypertension
AT hassounpaul whenmoreismoretheroleofadditionalupfronttherapyinpulmonaryarterialhypertension

Ejemplares similares